Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

Publisher: La Merie Publishing
Pages: 15
Format: PDF
Product Line:
Competitor Analysis
Product Code: LMCA0080
Release Date: April of 2013

150.00 €
Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
License:
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

Product description

The present Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO and IL-11) as of April 2013 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development. In addition, the report lists company-specific R&D pipelines of Thrombopoiesis Stimulating Agents (TPO; IL-11). Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects on the market and in research and development of thrombopoiesis stimulating agents for treatment of thrombocytopenia. In addition, the report lists company-specific product portfolios and R&D pipelines of Thrombopoiesis Stimulating Agents (TPO; IL-11). Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

 

Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

Table of Contents

  • Thrombopoietin  receptor  (TPO-R) activators
  • Interleukin-11 (IL-11) receptor activators
  • Small molecule TPO-R Agonists
  • Corporate TPO/IL-11 Receptor Agonist Product Portfolios and R&D Pipelines

 



The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top